Take a look at biocon story how they revolutionized diabetes management [1] and second check this report [2]. If more investments go in this area, India can very well be at par with US/UK and Germany in medtech, pharmaceutical and biotech areas.
Not sure what are you implying, this isn't true India plays by WTO and international rules [1]. It uses provisions enshrined in the bilateral treaty and also the rules of global trade. India still today do not support evergreening of patent's by incremental changes. It only grant patents to original innovations.
If you need more information about it probably read the 1970 patent act [2], in India which started those specific innovations in pharmaceutical formulations and made medicines affordable not just for India, but for most of Africa and many developing countries.
"Evergreening" isn't a legitimate practice but exist just as tax havens and gambling do.
The US is a very poor example of getting things right in healthcare, the prices of healthcare are inflated to astronomical rates so insurance can make a cool profit.
The price of medicines in the US is a poor scale to use across the world.
Yes, we all know it, but this is the only thing I know about biotech and Pharma in India. It doesn't really tell how "much more stronger" the industry is than IT, which is why I asked for a citation.
Interesting. I'd like to see a citation.